DANAHER Inactive Instrument
DANAHER Stock Other OTC
Equities
US2358513008
Advanced Medical Equipment & Technology
Financials (USD)
| Sales 2024 * | 24.03B | Sales 2025 * | 26.1B | Capitalization | 174B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.48B | Net income 2025 * | 5.38B | EV / Sales 2024 * | 7.49 x |
| Net Debt 2024 * | 5.55B | Net cash position 2025 * | 668M | EV / Sales 2025 * | 6.66 x |
| P/E ratio 2024 * |
39.6
x | P/E ratio 2025 * |
32.4
x | Employees | - |
| Yield 2024 * |
0.45% | Yield 2025 * |
0.48% | Free-Float | 74.94% |
More Fundamentals
* Assessed data
More news
Latest transcript on DANAHER
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 60 | 09-12-31 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
Alan Spoon
BRD | Director/Board Member | 72 | 99-06-30 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
2024-04-23
- Q1 2024 Earnings Release
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +2.64% | 207B | |
| +8.59% | 132B | |
| +16.47% | 99.1B | |
| -3.42% | 60.89B | |
| +12.71% | 52.04B | |
| -6.61% | 45.48B | |
| -4.53% | 38.81B | |
| +9.27% | 38.77B | |
| +3.97% | 26.09B |
